Cargando…
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder that currently lacks effective treatment. Berberine (BBR), a botanic compound isolated from traditional Chinese medicine, exhibits a potent therapeutic potential for the metabolic disease. The current study aimed to unde...
Autores principales: | Yuan, Xinlu, Wang, Jie, Tang, Xiaoyan, Li, Yixue, Xia, Pu, Gao, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316752/ https://www.ncbi.nlm.nih.gov/pubmed/25623289 http://dx.doi.org/10.1186/s12967-015-0383-6 |
Ejemplares similares
-
Berberine ameliorates vascular dysfunction by a global modulation of lncRNA and mRNA expression profiles in hypertensive mouse aortae
por: Tan, Na, et al.
Publicado: (2021) -
mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease
por: Matboli, Marwa, et al.
Publicado: (2021) -
Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
por: Tang, Xiaomei, et al.
Publicado: (2022) -
LncRNA Gm12664–001 ameliorates nonalcoholic fatty liver through modulating miR-295-5p and CAV1 expression
por: Zhang, Qiao, et al.
Publicado: (2020) -
LncRNA MALAT1 Promotes PPARα/CD36-Mediated Hepatic Lipogenesis in Nonalcoholic Fatty Liver Disease by Modulating miR-206/ARNT Axis
por: Xiang, Juan, et al.
Publicado: (2022)